Spanish National Cancer Research Center (CNIO), Genetic and Molecular Epidemiology Group, Madrid, and CIBERONC, Spain.
Karolinska Institutet and University Hospital, Gastrocentrum, Stockholm, Sweden.
Int J Epidemiol. 2018 Apr 1;47(2):473-483. doi: 10.1093/ije/dyx269.
Family history (FH) of pancreatic cancer (PC) has been associated with an increased risk of PC, but little is known regarding the role of inherited/environmental factors or that of FH of other comorbidities in PC risk. We aimed to address these issues using multiple methodological approaches.
Case-control study including 1431 PC cases and 1090 controls and a reconstructed-cohort study (N = 16 747) made up of their first-degree relatives (FDR). Logistic regression was used to evaluate PC risk associated with FH of cancer, diabetes, allergies, asthma, cystic fibrosis and chronic pancreatitis by relative type and number of affected relatives, by smoking status and other potential effect modifiers, and by tumour stage and location. Familial aggregation of cancer was assessed within the cohort using Cox proportional hazard regression.
FH of PC was associated with an increased PC risk [odds ratio (OR) = 2.68; 95% confidence interval (CI): 2.27-4.06] when compared with cancer-free FH, the risk being greater when ≥ 2 FDRs suffered PC (OR = 3.88; 95% CI: 2.96-9.73) and among current smokers (OR = 3.16; 95% CI: 2.56-5.78, interaction FHPC*smoking P-value = 0.04). PC cumulative risk by age 75 was 2.2% among FDRs of cases and 0.7% in those of controls [hazard ratio (HR) = 2.42; 95% CI: 2.16-2.71]. PC risk was significantly associated with FH of cancer (OR = 1.30; 95% CI: 1.13-1.54) and diabetes (OR = 1.24; 95% CI: 1.01-1.52), but not with FH of other diseases.
The concordant findings using both approaches strengthen the notion that FH of cancer, PC or diabetes confers a higher PC risk. Smoking notably increases PC risk associated with FH of PC. Further evaluation of these associations should be undertaken to guide PC prevention strategies.
胰腺癌(PC)家族史与 PC 风险增加相关,但关于遗传/环境因素的作用或其他合并症家族史在 PC 风险中的作用知之甚少。我们旨在使用多种方法学方法来解决这些问题。
包括 1431 例 PC 病例和 1090 例对照在内的病例对照研究,以及由其一级亲属(FDR)组成的重建队列研究(N=16747)。使用逻辑回归评估家族史中癌症、糖尿病、过敏、哮喘、囊性纤维化和慢性胰腺炎的相对类型和受影响亲属数量、吸烟状况和其他潜在的效应修饰物、肿瘤分期和位置与 PC 风险的关系。使用 Cox 比例风险回归评估队列内的癌症家族聚集性。
与无癌症家族史相比,PC 家族史与 PC 风险增加相关(优势比[OR] = 2.68;95%置信区间[CI]:2.27-4.06),当≥2 名 FDR 患有 PC 时风险更大(OR=3.88;95%CI:2.96-9.73),并且在当前吸烟者中风险更大(OR=3.16;95%CI:2.56-5.78,FHPC*吸烟 P 值=0.04)。病例 FDR 的 75 岁时 PC 累积风险为 2.2%,而对照 FDR 的为 0.7%[风险比(HR)=2.42;95%CI:2.16-2.71]。PC 风险与癌症家族史(OR=1.30;95%CI:1.13-1.54)和糖尿病家族史(OR=1.24;95%CI:1.01-1.52)显著相关,但与其他疾病家族史无关。
两种方法的一致发现加强了这样一种观点,即癌症、PC 或糖尿病的家族史会增加 PC 的风险。吸烟显著增加了与 PC 家族史相关的 PC 风险。应进一步评估这些关联,以指导 PC 预防策略。